Patrick McCabe1, Artin Galoosian2, Robert J Wong3. 1. Division of Gastroenterology and Hepatology, Department of Medicine, California Pacific Medical Center, San Francisco, CA, USA. 2. Department of Medicine, California Pacific Medical Center, San Francisco, CA, USA. 3. Division of Gastroenterology and Hepatology, Alameda Health System - Highland Hospital, 1411 East 31st Street, Highland Hospital - Highland, Care Pavilion 5th Floor, Endoscopy Unit, Oakland, CA, 94602, USA. Rowong@alamedahealthsystem.org.
Abstract
BACKGROUND: Worse functional status correlates with increased mortality on the liver transplant (LT) waitlist. Whether functional status affects LT outcomes equally across cirrhosis etiologies is unclear. AIMS: We evaluate the impact of functional status on waitlist and post-LT mortality stratified by etiology and age. METHODS: Functional status among US adults from 2005 to 2017 United Network for Organ Sharing LT registry data was retrospectively evaluated using Karnofsky Performance Status Score (KPS-1 = functional status 80-100%, KPS-2 = 60-70%, KPS-3 = 40-50%, KPS-4 = 10-30%). Waitlist and post-LT survival were stratified by KPS and cirrhosis etiology, including alcoholic liver disease (ALD), nonalcoholic steatohepatitis (NASH), hepatitis C (HCV), and HCV/ALD, and evaluated using Kaplan-Meier and multivariate Cox proportional hazard models. RESULTS: Among 94,201 waitlist registrants (69.4% men, 39.5% HCV, 26.7% ALD, 23.2% NASH), ALD patients had worse functional status compared to HCV (KPS-4: 17.2% vs. 8.3%, p < 0.001). Worse functional status at time of waitlist registration was associated with higher 90-day waitlist mortality with the greatest effect in ALD (KPS-4 vs. KPS-1: ALD HR 2.16, 95% CI 1.83-2.55; HCV HR 2.17, 95% CI 1.87-2.51). Similar trends occurred in 5-year post-LT survival with ALD patients the most harmed. Compared to patients < 50 years, patients ≥ 65 years had increased waitlist mortality at 90-days if they had HCV or HCV/ALD, and 5-year post-LT mortality regardless of cirrhosis etiology with ALD patients most severely affected. CONCLUSIONS: In a retrospective cohort study of patients, US ALD patients had disparately worse functional status at time of LT waitlist registration. Worse functional status correlated with higher risk of waitlist and post-LT mortality, affecting ALD and HCV patients the most.
BACKGROUND: Worse functional status correlates with increased mortality on the liver transplant (LT) waitlist. Whether functional status affects LT outcomes equally across cirrhosis etiologies is unclear. AIMS: We evaluate the impact of functional status on waitlist and post-LT mortality stratified by etiology and age. METHODS: Functional status among US adults from 2005 to 2017 United Network for Organ Sharing LT registry data was retrospectively evaluated using Karnofsky Performance Status Score (KPS-1 = functional status 80-100%, KPS-2 = 60-70%, KPS-3 = 40-50%, KPS-4 = 10-30%). Waitlist and post-LT survival were stratified by KPS and cirrhosis etiology, including alcoholic liver disease (ALD), nonalcoholic steatohepatitis (NASH), hepatitis C (HCV), and HCV/ALD, and evaluated using Kaplan-Meier and multivariate Cox proportional hazard models. RESULTS: Among 94,201 waitlist registrants (69.4% men, 39.5% HCV, 26.7% ALD, 23.2% NASH), ALDpatients had worse functional status compared to HCV (KPS-4: 17.2% vs. 8.3%, p < 0.001). Worse functional status at time of waitlist registration was associated with higher 90-day waitlist mortality with the greatest effect in ALD (KPS-4 vs. KPS-1: ALD HR 2.16, 95% CI 1.83-2.55; HCV HR 2.17, 95% CI 1.87-2.51). Similar trends occurred in 5-year post-LT survival with ALDpatients the most harmed. Compared to patients < 50 years, patients ≥ 65 years had increased waitlist mortality at 90-days if they had HCV or HCV/ALD, and 5-year post-LT mortality regardless of cirrhosis etiology with ALDpatients most severely affected. CONCLUSIONS: In a retrospective cohort study of patients, US ALDpatients had disparately worse functional status at time of LT waitlist registration. Worse functional status correlated with higher risk of waitlist and post-LT mortality, affecting ALD and HCV patients the most.
Authors: Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers Journal: Liver Transpl Date: 2012-10 Impact factor: 5.799
Authors: Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed Journal: Gastroenterology Date: 2014-11-25 Impact factor: 22.682
Authors: Maggie M G Ow; Paul Erasmus; Gary Minto; Richard Struthers; Moby Joseph; Aileen Smith; Usama M Warshow; Matthew E Cramp; Tim J S Cross Journal: Liver Transpl Date: 2014-08-04 Impact factor: 5.799
Authors: Michał Grąt; Zbigniew Lewandowski; Karolina Grąt; Karolina Maria Wronka; Maciej Krasnodębski; Krzysztof Barski; Hanna Zborowska; Waldemar Patkowski; Krzysztof Zieniewicz; Marek Krawczyk Journal: Clin Transplant Date: 2014-08-22 Impact factor: 2.863
Authors: Andrés Duarte-Rojo; Astrid Ruiz-Margáin; Aldo J Montaño-Loza; Ricardo U Macías-Rodríguez; Arny Ferrando; W Ray Kim Journal: Liver Transpl Date: 2018-01 Impact factor: 5.799
Authors: Chelsea Q Xu; Frederick Yao; Yara Mohamad; Randi Wong; Dorothea Kent; Srilakshmi Seetharaman; Yanin Srisengfa; Jennifer C Lai Journal: Transplant Direct Date: 2021-01-07
Authors: Chelsea Q Xu; Yara Mohamad; Matthew R Kappus; Brian Boyarsky; Daniel R Ganger; Michael L Volk; Robert S Rahimi; Andres Duarte-Rojo; Mara McAdams-DeMarco; Dorry L Segev; Daniela P Ladner; Elizabeth C Verna; Joshua Grab; Monica Tincopa; Michael A Dunn; Jennifer C Lai Journal: Liver Int Date: 2021-07-14 Impact factor: 8.754